<img alt="" height="1" width="1" />Ironwood Pharmaceutical's IPO Terms Set at 16.67M â€" CBLwww.citybizlist.com (press release)Ironwood, which has about 200 employees, is in Phase 3 clinical trials for a drug called Linaclotide which treats irritable bowel syndrome and constipation. ...Early stage pharmaceutical company Ironwood announces IPO terms<nobr>Renaissance Capital</nobr>Ironwood Pharma prices IPO up to $267M<nobr>Mass High Tech</nobr><nobr>all 16 news articles »</nobr> |